| abstract |
In some aspects, this disclosure is directed to a method of treating chronic graft versus host disease (cGVHD). In some embodiments, the method comprises administering to a subject in need of such treatment an EZH2 inhibitor, a Bcl6 inhibitor and / or a BRD4 inhibitor. This disclosure is based, at least in part, on the use of a medicament for the treatment of chronic graft versus host disease (e. G., EZH2 inhibitor, B-cell lymphoma 6 protein (Bcl6) inhibitor and / RTI ID = 0.0 > cGVHD). < / RTI > |